| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1045035038 |
| P356 | DOI | 10.1023/A:1012739815892 |
| P698 | PubMed publication ID | 11768269 |
| P50 | author | Santiago Vivas | Q64517737 |
| P2093 | author name string | J L Alonso | |
| M Rodriguez | |||
| L Rodrigo | |||
| M A Palacio | |||
| A Linares | |||
| P2860 | cites work | Factors related to early mortality in cirrhotic patients bleeding from varices and treated by urgent sclerotherapy | Q34396567 |
| Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis | Q34503648 | ||
| A prospective evaluation of bacteremic patients with chronic liver disease | Q40783297 | ||
| A prospective study of bacterial infections in patients with cirrhosis | Q44384377 | ||
| Macrophage function in cirrhosis and the risk of bacterial infection | Q44398321 | ||
| Bacterial infection in the pathogenesis of variceal bleeding. | Q54104969 | ||
| Hemorrhagic shock induces bacterial translocation from the gut. | Q54745742 | ||
| Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage | Q57181564 | ||
| Prognostic significance of bacterial infection in bleeding cirrhotic patients: A prospective study | Q58034650 | ||
| Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage | Q61577655 | ||
| Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage | Q67555298 | ||
| Effect of hemorrhagic shock on bacterial translocation, intestinal morphology, and intestinal permeability in conventional and antibiotic-decontaminated rats | Q68759499 | ||
| Frequency of infections in cirrhotic patients presenting with acute gastrointestinal haemorrhage | Q68805077 | ||
| Prognostic indicators in acute variceal hemorrhage after treatment by schlerotherapy | Q68824044 | ||
| Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection | Q71650807 | ||
| Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage | Q72036594 | ||
| A prospective randomized trial comparing somatostatin and sclerotherapy in the treatment of acute variceal bleeding | Q72686329 | ||
| A predictive model for failure to control bleeding during acute variceal haemorrhage | Q72995525 | ||
| The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding | Q74730523 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 2752-2757 | |
| P577 | publication date | 2001-12-01 | |
| P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
| P1476 | title | Presence of bacterial infection in bleeding cirrhotic patients is independently associated with early mortality and failure to control bleeding | |
| P478 | volume | 46 |
| Q92120563 | Antibiotic use in cirrhotic children with acute upper gastrointestinal bleeding: A retrospective study using the pediatric health information system (PHIS) database |
| Q26781714 | Coagulopathy in liver disease: Lack of an assessment tool |
| Q38222435 | Current Management Strategies for Acute Esophageal Variceal Hemorrhage |
| Q36090423 | Improving survival in decompensated cirrhosis |
| Q34400962 | Infection, coagulation, and variceal bleeding in cirrhosis |
| Q89502154 | KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications |
| Q57824689 | Management of Infectious Complications Associated with Acute-on-Chronic Liver Failure |
| Q37682044 | Management of the Cirrhotic Patient Before Liver Transplantation: The Role of the Referring Gastroenterologist |
| Q21284997 | Microbial translocation in chronic liver diseases |
| Q35744431 | Predicting risk factors for rebleeding, infections, mortality following peptic ulcer bleeding in patients with cirrhosis and the impact of antibiotics prophylaxis at different clinical stages of the disease. |
| Q35201824 | Prevention and management of bacterial infections in cirrhosis |
| Q34638216 | Prevention and management of gastroesophageal varices in cirrhosis |
| Q49717262 | Prevention and management of gastroesophageal varices. |
| Q40328812 | Prognostic factors associated with mortality in patients with gastric fundal variceal bleeding |
| Q34992538 | Review article: the molecular adsorbents recirculating system (MARS) in liver failure. |
| Q35597315 | Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. |
| Q24645324 | Spontaneous bacterial peritonitis: a review of treatment options |
| Q37791935 | Spontaneous bacterial peritonitis: from pathophysiology to prevention |
| Q64964975 | Strategies to avoid empiric blood product administration in liver transplant surgery. |
| Q38552207 | The effect of systemic antibiotic prophylaxis for cirrhotic patients with peptic ulcer bleeding after endoscopic interventions |
| Q33560472 | The influential roles of antibiotics prophylaxis in cirrhotic patients with peptic ulcer bleeding after initial endoscopic treatments |
| Q34830328 | The pathophysiological basis of acute-on-chronic liver failure |
| Q41843561 | Upper gastrointestinal haemorrhage: an update |
| Q35435269 | Using transjugular intrahepatic portosystemic shunts for complications of cirrhosis |
| Q33724083 | Venous thromboembolism in cirrhosis |
| Q80103103 | [Evaluation and non-specific management of upper gastrointestinal bleeding due to rupture of esophageal varices] |
| Q80103186 | [Gastrointestinal hemorrhage. Failure of pharmacological and endoscopic treatments: what is to be done?] |
| Q80103226 | [How to treat and to prevent spontaneous bacterial peritonitis?] |
| Q79711880 | [Infection and variceal bleeding in cirrhosis] |
| Q80052049 | [Infection during cirrhosis] |
Search more.